# AZD8601 Study in CABG Patients

> **NCT03370887** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 11 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** AZD8601
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03370887
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-05
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370887, "AZD8601 Study in CABG Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03370887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*